BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27306686)

  • 1. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.
    Yap SA; Yuh LM; Evans CP; Dall'Era MA; Wagenaar RM; Cress R; Lara PN
    World J Urol; 2017 Feb; 35(2):277-283. PubMed ID: 27306686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.
    Kamran SC; Seisen T; Markt SC; Preston MA; Trinh QD; Frazier LA; Choueiri TK; Martin NE; Nguyen PL; Beard CJ
    Eur Urol; 2018 Feb; 73(2):262-270. PubMed ID: 28687143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy analysis of three therapeutic modes on clinical stage Ia nonseminomatous germ cell testicular tumors].
    Dong P; Liu ZW; Li XD; Wu S; Li YH; Yao K; Qin ZK; Han H; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):256-60. PubMed ID: 23859330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer Database.
    Weiner AB; Pearce SM; Eggener SE
    Cancer; 2017 Jan; 123(2):245-252. PubMed ID: 27626903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical study of testicular tumors].
    Matsuki H; Ozono S; Arai K; Saka M; Cho M; Nakagawa Y; Kaneko Y; Yoshida K; Okamoto S; Maruyama Y
    Hinyokika Kiyo; 1988 Oct; 34(10):1757-65. PubMed ID: 2854363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia.
    Ruf CG; Gnoss A; Hartmann M; Matthies C; Anheuser P; Loy V; Pichlmeier U; Dieckmann KP
    Andrology; 2015 Jan; 3(1):92-8. PubMed ID: 25146646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
    Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
    Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
    Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
    Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of stage I nonseminomatous testicular germ cell tumors.
    Pectasides D; Farmakis D; Pectasides M
    Oncology; 2006; 71(3-4):151-8. PubMed ID: 17646698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
    Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
    PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of nonseminomatous germ cell tumors in pediatric patients and young adults - A stage group stratified analysis.
    Srivastava A; Patel HV; Koehne E; Gupta GN; Drachtman R; Pierorazio PM; Bagrodia A; Elsamra SE; Kim IY; Ghodoussipour S; Singer EA; Jang TL; Patel HD; Barone JG
    Urol Oncol; 2022 Apr; 40(4):169.e1-169.e12. PubMed ID: 35144865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients.
    John A; Baumgart A; Worst T; Heinzelbecker J
    Urol Int; 2018; 100(3):279-287. PubMed ID: 29514158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary treatment of low risk stage I non-seminomatous germ cell testicular tumors: a survey of the Society of Urologic Oncology.
    Alanee S; Nicholson A; Slaton J
    Urol Oncol; 2012; 30(6):749-51. PubMed ID: 23359888
    [No Abstract]   [Full Text] [Related]  

  • 20. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
    Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
    Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.